Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Biol Chem ; 296: 100216, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33465377

RESUMO

For most G protein-coupled receptors, the third intracellular loop (IL3) and carboxy-terminal tail (CT) are sites for G protein-coupled receptor kinase (GRK)-mediated phosphorylation, leading to ß-arrestin binding and agonist-specific desensitization. These regions of bitter taste receptors (TAS2Rs) are extremely short compared with the superfamily, and their function in desensitization is unknown. TAS2R14 expressed on human airway smooth muscle cells relax the cell, suggesting a novel target for bronchodilators. To assess IL3 and CT in agonist-promoted TAS2R14 desensitization (tachyphylaxis), we generated fusion proteins of both the WT sequence and Ala substituted for Ser/Thr in the IL3 and CT sequences. In vitro, activated GRK2 phosphorylated WT IL3 and WT CT proteins but not Ala-substituted forms. TAS2R14s with mutations in IL3 (IL-5A), CT (CT-5A), and in both regions (IL/CT-10A) were expressed in human embryonic kidney 293T cells. IL/CT-10A and CT-5A failed to undergo desensitization of the intracellular calcium response compared with WT, indicating that functional desensitization by GRK phosphorylation is at residues in the CT. Desensitization of TAS2R14 was blocked by GRK2 knockdown in human airway smooth muscle cells. Receptor:ß-arrestin binding was absent in IL/CT-10A and CT-5A and reduced in IL-5A, indicating a role for IL3 phosphorylation in the ß-arrestin interaction for this function. Agonist-promoted internalization of IL-5A and CT-5A receptors was impaired, and they failed to colocalize with early endosomes. Thus, agonist-promoted functional desensitization of TAS2R14 occurs by GRK phosphorylation of CT residues and ß-arrestin binding. However, ß-arrestin function in the internalization and trafficking of the receptor also requires GRK phosphorylation of IL3 residues.


Assuntos
Quinase 2 de Receptor Acoplado a Proteína G/metabolismo , Miócitos de Músculo Liso/metabolismo , Processamento de Proteína Pós-Traducional , RNA Interferente Pequeno/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Substituição de Aminoácidos , Brônquios/citologia , Brônquios/metabolismo , Cálcio/metabolismo , Difenidramina/farmacologia , Endossomos/metabolismo , Quinase 2 de Receptor Acoplado a Proteína G/antagonistas & inibidores , Quinase 2 de Receptor Acoplado a Proteína G/química , Quinase 2 de Receptor Acoplado a Proteína G/genética , Genes Reporter , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Células HEK293 , Humanos , Mutação , Miócitos de Músculo Liso/citologia , Miócitos de Músculo Liso/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Ligação Proteica , RNA Interferente Pequeno/genética , Receptores Acoplados a Proteínas G/química , Receptores Acoplados a Proteínas G/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Taquifilaxia/genética , Proteínas de Transporte Vesicular/genética , Proteínas de Transporte Vesicular/metabolismo , beta-Arrestinas/genética , beta-Arrestinas/metabolismo
3.
Lung Cancer ; 81(2): 302-5, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23683536

RESUMO

We report the case of an 80-year-old male with relapsed EGFR exon 19 deletion lung adenocarcinoma treated with EGFR-tyrosine kinase inhibitor (TKI), but with poor response and rapid increase of serum neuron specific enolase (NSE). Repeat biopsy identified pathological transformation to small cell lung cancers (SCLC) retaining the same EGFR mutation. This case highlights routine serological testing of NSE may benefit for the lung adenocarcinoma patients resistant to TKIs.


Assuntos
Adenocarcinoma/patologia , Transformação Celular Neoplásica/genética , Receptores ErbB/genética , Neoplasias Pulmonares/patologia , Fosfopiruvato Hidratase/sangue , Carcinoma de Pequenas Células do Pulmão/patologia , Taquifilaxia/genética , Adenocarcinoma/sangue , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/genética , Adenocarcinoma de Pulmão , Idoso de 80 Anos ou mais , Humanos , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/genética , Masculino , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Tirosina Quinases/antagonistas & inibidores , Carcinoma de Pequenas Células do Pulmão/sangue , Carcinoma de Pequenas Células do Pulmão/tratamento farmacológico , Carcinoma de Pequenas Células do Pulmão/genética
4.
J Neurophysiol ; 106(6): 3056-66, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21900509

RESUMO

The cold-sensing channel transient receptor potential melastatin 8 (TRPM8) features Ca(2+)-dependent downregulation, a cellular process underlying somatosensory accommodation in cold environments. The Ca(2+)-dependent functional downregulation of TRPM8 is manifested with two distinctive phases, acute desensitization and tachyphylaxis. Here we show in rat dorsal root ganglion neurons that TRPM8 acute desensitization critically depends on phosphatidylinositol 4,5-bisphosphate (PIP(2)) availability rather than PIP(2) hydrolysis and is triggered by calmodulin activation. Tachyphylaxis, on the other hand, is mediated by phospholipase hydrolysis of PIP(2) and protein kinase C/phosphatase 1,2A. We further demonstrate that PIP(2) switches TRPM8 channel gating to a high-open probability state with short closed times. Ca(2+)-calmodulin reverses the effect of PIP(2), switching channel gating to a low-open probability state with long closed times. Thus, through gating modulation, Ca(2+)-calmodulin provides a mechanism to rapidly regulate TRPM8 functions in the somatosensory system.


Assuntos
Calmodulina/farmacologia , Regulação para Baixo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fosfatidilinositol 4,5-Difosfato/farmacologia , Canais de Cátion TRPM/metabolismo , Taquifilaxia/fisiologia , Análise de Variância , Animais , Biofísica , Cálcio/metabolismo , Células Cultivadas , Quelantes/farmacologia , Temperatura Baixa , Interações Medicamentosas , Ácido Egtázico/análogos & derivados , Ácido Egtázico/farmacologia , Estimulação Elétrica , Inibidores Enzimáticos/farmacologia , Feminino , Gânglios Espinais/citologia , Humanos , Ativação do Canal Iônico/efeitos dos fármacos , Ativação do Canal Iônico/genética , Isotiocianatos/farmacologia , Masculino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Mentol/farmacologia , Técnicas de Patch-Clamp , Ratos , Ratos Sprague-Dawley , Canais de Cátion TRPM/genética , Taquifilaxia/genética , Fatores de Tempo , Transfecção
6.
Neurol Sci ; 29 Suppl 2: S216-7, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18690496

RESUMO

The therapeutic benefits of interferon-beta are limited, as some patients with multiple sclerosis (MS) do not respond to therapy. Based on their biological characteristics, non-responsive patients can be divided into three subgroups: genetic, pharmacological and pathogenetic non-responders. In order to tailor the best treatment in both newly diagnosed MS patients and those already receiving treatment, the neurologist must carefully consider the risk of treating non-responders.


Assuntos
Resistência a Medicamentos/imunologia , Interferon beta/farmacologia , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/tratamento farmacológico , Biomarcadores/análise , Resistência a Medicamentos/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Regulação da Expressão Gênica/imunologia , Humanos , Tolerância Imunológica/efeitos dos fármacos , Tolerância Imunológica/genética , Tolerância Imunológica/imunologia , Fatores Imunológicos/farmacologia , Esclerose Múltipla/fisiopatologia , Receptor de Interferon alfa e beta/genética , Receptor de Interferon alfa e beta/imunologia , Taquifilaxia/genética , Taquifilaxia/imunologia , Resultado do Tratamento
7.
FASEB J ; 22(9): 3298-309, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18559878

RESUMO

Transient receptor potential vanilloid receptor subtype I (TRPV1) is an ion channel gated by physical and chemical stimuli that belongs to the TRPV protein family. TRPV receptors contain a highly conserved, 6-mer segment near the channel gate, known as the TRP box, whose function remains unknown. Here, we performed an alanine scanning mutagenesis of the TRP box of TRPV1 (IWKLQR) and found that mutation of this motif affected channel gating by raising the free energy of channel activation. Functional characterization of TRPV1 mutants showed that substitution of I696, W697, and R701 by alanine severely affected voltage- and heat-dependent activation and notably reduced the capsaicin responsiveness and tachyphylaxia, while mutation of K698, L699, and Q700 had minor effects. In addition, mutation of I696 to alanine promoted a strong outward rectification at negative membrane potentials, and slowed the kinetics of channel activation. Taken together, our findings suggest that modification of I696, W697, and R701 to alanine altered channel function by affecting events downstream of the initial stimuli-sensing step and imply that intersubunit interactions within the TRP box play an important role in TRPV1 gating.


Assuntos
Ativação do Canal Iônico/fisiologia , Canais de Cátion TRPV/química , Sequência de Aminoácidos , Capsaicina/farmacologia , Células Cultivadas , Temperatura Alta , Humanos , Ativação do Canal Iônico/efeitos dos fármacos , Mutação , Técnicas de Patch-Clamp , Canais de Cátion TRPV/genética , Taquifilaxia/genética , Transfecção
8.
Am J Physiol Endocrinol Metab ; 293(1): E252-8, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17389713

RESUMO

To examine the role of the brain stem melanocortin system in long-term energy regulation, we assessed the effects of overproduction of proopiomelanocortin (POMC) in the caudal brain stem of F344xBN rats with adult-onset obesity. Recombinant adeno-associated viral vector encoding POMC gene was delivered to the nucleus of solitary tract (NTS) in the hindbrain, and food intake, body weight, glucose and fat metabolism, brown adipose tissue thermogenesis, and mRNA levels of neuropeptides and melanocortin receptors were assessed. POMC delivery resulted in sustained reduction in food intake and body weight over 42 days and improved insulin sensitivity. At death, in recombinant adeno-associated viral vector-POMC-treated rats vs. control rats, alpha-melanocyte-stimulating hormone in NTS increased nearly 21-fold, whereas hypothalamic alpha-melanocyte-stimulating hormone remained unchanged. Visceral adiposity decreased by 37%; tissue triglyceride content diminished by 26% and 47% in liver and muscle, respectively; serum triglyceride and nonesterified fatty acids were reduced by 35% and 34%, respectively; phosphorylation of acetyl-CoA carboxylase was elevated by 63% in soleus muscle; brown adipose tissue uncoupling protein 1 increased by 30%; and melanocortin 3 receptor expression declined by 60%, whereas neuropeptide Y, agouti-related protein, and MC4 receptor mRNA levels were unchanged in the NTS. In conclusion, POMC overexpression in the NTS produces a characteristic unabated hypophagia that is uniquely different from the anorexic tachyphylaxis following POMC overexpression in the hypothalamus. The sustained anorectic response may result from absence of compensatory elements in the NTS, such as increased agouti-related protein expression, suggesting melanocortin activation of the brain stem may be a viable strategy to alleviate obesity.


Assuntos
Anorexia/prevenção & controle , Melanocortinas/genética , Núcleo Solitário/metabolismo , Taquifilaxia , Redução de Peso/genética , Adiposidade/genética , Animais , Animais Geneticamente Modificados , Anorexia/induzido quimicamente , Regulação do Apetite/genética , Peso Corporal , Metabolismo Energético/genética , Regulação da Expressão Gênica , Técnicas de Transferência de Genes , Terapia Genética , Leptina/sangue , Masculino , Melanocortinas/metabolismo , Obesidade/genética , Obesidade/metabolismo , Obesidade/terapia , Pró-Opiomelanocortina/genética , Pró-Opiomelanocortina/metabolismo , Ratos , Ratos Endogâmicos F344 , Taquifilaxia/genética , Fatores de Tempo , alfa-MSH/genética , alfa-MSH/metabolismo
9.
Alcohol Clin Exp Res ; 30(2): 194-202, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16441268

RESUMO

This article summarizes the proceedings of a symposium presented at the 2005 Research Society on Alcoholism meeting in Santa Barbara, California. This symposium begins with a description by Michael Windle of structural equation modeling (SEM), including the assets and liabilities of this approach. Next, Marc Schuckit and Tom Smith demonstrate the application of an SEM approach to understanding the impact of a low level of response to alcohol, using data from both adolescent and adult populations. Victor Hesselbrock and colleagues next review the results when an SEM approach is used in the longitudinal study of externalizing behaviors. This is followed by a description of the application of SEM to an affect-related model as discussed by John Kramer and Kathleen Bucholz. Finally, Kenneth Sher offers thoughts on how to place these findings into perspective.


Assuntos
Intoxicação Alcoólica/epidemiologia , Alcoolismo/epidemiologia , Modelos Estatísticos , Adaptação Psicológica , Adolescente , Adulto , Intoxicação Alcoólica/genética , Intoxicação Alcoólica/psicologia , Alcoolismo/genética , Alcoolismo/psicologia , Criança , Comorbidade , Predisposição Genética para Doença/genética , Humanos , Controle Interno-Externo , Computação Matemática , Meio Social , Software , Taquifilaxia/genética
10.
Respir Med ; 100(6): 1072-8, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16263254

RESUMO

BACKGROUND: The study of determinants of asthma is a subject of much interest currently, especially the pharmacogenetic aspects of asthma management. Genetic polymorphisms affecting amino-acids at positions 16 and 27 within beta(2)-adrenoceptor (beta(2)AR) gene have been implicated in the asthma phenotypes and influence on the variability observed in response to use of bronchodilator agents used in the treatment of asthma. Whether these polymorphisms alter the bronchoprotection response to beta(2)-agonist treatment in Spanish asthmatic population is unknown. The aim of this study was to investigate whether genetic polymorphisms within beta(2)AR gene modulate the clinical outcomes of the individual response to beta(2)-agonist therapy and the development of desensitization in Spanish asthmatic patients. METHODS: In a prospective, case-control study were included 80 asthmatic patients. Based on the standard criteria, patients were classified into two groups: patients with tachyphylaxis and good responders to beta(2)-agonist therapy. DNA samples were genotyped for the Arg(16)Gly and Glu(27)Gln alleles within the beta(2)AR gene as well as in 64 control samples from blood donors. RESULTS: Arg(16) allele was slightly more frequent within the group with tachyphylaxis (P=0.039), whereas Gly(16) allele carriers were overrepresented within the group of good responders (59.7%, P=0.028). On the other hand, the allele frequency of Gln(27) and the proportion of Gln(27) carriers was higher within the group with tachyphylaxis (P=0.010 and 0.049, respectively) and Glu(27) allele carriers were overrepresented within the group of good responders (P=0.026). The Arg(16) and Gln(27) alleles were in strong linkage disequilibrium across this locus, resulting in the occurrence of disease haplotype. CONCLUSIONS: The predisposition to develop tachyphylaxis in our population seems to be linked to the Arg(16) and Gln(27) alleles and to the Arg(16)/Gln(27) risk haplotype (positive association between the presence of the Arg(16) and Gln(27) alleles and tachyphylaxis). The Arg(16) allele is perhaps overrepresented due to the strong linkage disequilibrium between both polymorphisms. The presence of the Glu(27) allele seems to be a protective factor against tachyphylaxis in this cohort study.


Assuntos
Agonistas Adrenérgicos beta/uso terapêutico , Asma/genética , Polimorfismo Genético , Receptores Adrenérgicos beta 2/genética , Taquifilaxia/genética , Adolescente , Adulto , Alelos , Asma/tratamento farmacológico , Testes de Provocação Brônquica , Estudos de Casos e Controles , Esquema de Medicação , Feminino , Frequência do Gene , Haplótipos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Falha de Tratamento
11.
Eur J Pharmacol ; 476(1-2): 25-30, 2003 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-12969745

RESUMO

We have previously demonstrated that Chinese hamster ovary (CHO) cells transfected with the angiotensin II AT1 receptor gene containing only the coding region, presented tachyphylaxis to the total inositol phosphate (InsPs) and Ca2+ responses mediated by angiotensin II and [2-lysine]angiotensin II ([Lys2]angiotensin II). Now we have evaluated the possible role of the 3'-untranslated region of the angiotensin AT1 receptor mRNA in modulating the angiotensin AT1 receptor-mediated cellular responses. The binding parameters, as well as the Ca2+ and InsPs responses induced by angiotensin II and [Lys2]angiotensin II were similar in cells transfected with the angiotensin AT1 receptor with or without the 3'-untranslated region sequence. In cells transfected with the receptor containing the 3'-untranslated region sequence, angiotensin II-induced Ca2+ and InsPs responses were desensitized by repeated stimulations, whereas [Lys2]angiotensin II caused desensitization of InsPs production but not of Ca2+ uptake in these cells. Our results suggest that the 3'-untranslated region plays a role in modulating cell signalling involved in the tachyphylaxis of angiotensin AT1 receptor-mediated Ca2+ responses.


Assuntos
Regiões 3' não Traduzidas/fisiologia , Angiotensina II/análogos & derivados , Angiotensina II/metabolismo , Receptor Tipo 1 de Angiotensina/fisiologia , Angiotensina II/farmacologia , Animais , Sítios de Ligação , Células CHO , Cálcio/metabolismo , Cricetinae , Fosfatos de Inositol/biossíntese , Ratos , Receptor Tipo 1 de Angiotensina/genética , Receptor Tipo 1 de Angiotensina/metabolismo , Taquifilaxia/genética , Taquifilaxia/fisiologia , Transfecção
12.
Drugs ; 51(4): 552-70, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8706594

RESUMO

The lack of (or poor) response to drugs has very important medical, social and economic consequences today. An unsatisfactory response to treatment implies not only a worsening or prolongation of the pathological state, but also prolonged hospitalisation, longer withdrawal from social and active life, and waste of community resources. Poor response to drugs has many and varied causes, among which 4 major categories can be identified: pharmacokinetic, cellular, genetic and medical. After a brief description of the terminology, the phenomena of tachyphylaxis, tolerance and drug resistance are analysed and critically described on the basis of the available evidence. Whenever possible, alternative or operative behaviours aimed at reducing the incidence of the above phenomena are commented on. On the question of medical causes, irrational prescriptions and poor compliance with the prescribed regimen stand as two major issues whose prevalence is worrying. In order to limit the waste of professional responsibility and economic resources, efforts aimed at reducing the present insufficiencies are needed at organisational and educational levels.


Assuntos
Resistência a Medicamentos/genética , Tratamento Farmacológico/normas , Tolerância a Medicamentos/genética , Farmacocinética , Taquifilaxia/genética , Regulação para Baixo , Uso de Medicamentos , Humanos , Nitratos/efeitos adversos , Nitratos/uso terapêutico , Cooperação do Paciente , Terminologia como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...